SBC Medical Group Holdings Inc. (NASDAQ: SBC), a Japanese operator of aesthetic medical clinics, has completed a strategic investment in OrangeTwist, a U.S.-based medspa chain, marking its official foray into the American market. The partnership aims to combine SBC's operational expertise with OrangeTwist's advanced management system to capture growth in the medical aesthetics industry, which is forecast to grow from $34 billion to $48 billion by 2030.
OrangeTwist, which operates 24 locations across six U.S. states, specializes in non-invasive treatments such as injectables, energy-based therapies, and regenerative procedures. The two companies plan to pursue joint operations, leveraging synergies in the U.S. and Asia. SBC will provide funding and professional know-how to enhance OrangeTwist's offerings, support faster expansion into underserved markets—referred to as "white space"—and develop branded products together.
Stephen Rodgers, global head of planning and strategy at SBC Medical, told Benzinga in an interview that the company seeks local partnerships aligned with its mission, rather than replicating its Japanese model. "As part of SBC’s global expansion, we are working hard to find local partnerships rather than copying and pasting what we did in Japan," Rodgers said. He emphasized that SBC looks for partners in leadership positions with scalable models, similar to OrangeTwist.
Beyond aesthetics, SBC aims to capitalize on the longevity industry, which is shifting from increasing lifespan to boosting "healthspan" through personalized, preventative, and tech-driven solutions. The global anti-aging market is expected to surpass $120 billion by 2030, with North America accounting for approximately 30% of the market, according to Gabelli Research. Key trends include AI-powered diagnostics, GLP-1 weight-loss drugs, and regenerative therapies, areas where SBC is positioned to offer services through its existing infrastructure.
In addition to the U.S., SBC is expanding in Japan and Southeast Asia, applying its proven business model to help Asian clinics with one-stop management, staff training, and equipment pricing. The company's global strategy rests on partnering with high-performing regional operators, deploying expertise to drive efficiencies, and securing first-mover advantages. Non-invasive cosmetic treatments are particularly suited for Asian markets due to patient preferences for natural-looking results with minimal recovery time.
SBC Medical, which already manages over six million patient visits annually through 258 affiliated clinics worldwide, is building a global network by creating a partnership model replicable across countries. By sharing its successful approach with local providers, the company aims to establish a trusted brand offering aesthetic beauty services globally. To learn more about SBC Medical, click here.
Featured image from Shutterstock. This content was originally published on Benzinga. Read further disclosures here.
